Abstract _ Full Text (HTML) _ Full Text (PDF)

Review

Cancer Research Frontiers. 2015 Apr; 1(2): 162-171. doi: 10.17980/2015.162

Localized Management of Soft Tissue Sarcoma Metastasis: A Review of a Multidisciplinary Approach.

Meena Bedi1[*], David M. King2, Hina Saeed1, Sean Tutton3, John A. Charlson4, Donald A. Hackbarth2, John C. Neilson2

Departments of Radiation Oncology1, Orthopaedic Surgery2, Interventional Radiology3, and Medical Oncology4 at the Medical College of Wisconsin.

 

[*]Corresponding author: Meena Bedi, MD, Department of Radiation Oncology, Medical College of Wisconsin, 8701 Watertown Plank Rd, Milwaukee, WI 53045, United States; Tel: (414) 805-4496; Fax: (414) 805-4405; Email: mbedi@mcw.edu

Citation: Bedi M, et al. Localized Management of Soft Tissue Sarcoma Metastasis: A Review of a Multidisciplinary Approach. Cancer Research Frontiers. 2015 Apr; 1(2): 162-171. doi: 10.17980/2015.162

Copyright: @ 2015 Bedi M, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Competing Interests: The authors declare that they have no competing interests.

Received January 1, 2015; Revised April 17, 2015; Accepted April 29, 2015.

 

ABSTRACT

The rate of distant metastasis from soft tissue sarcoma (STS) primaries ranges from 25-30%. The most common site of distant spread is hematogenously to the lung, however other sites of metastasis may occur, particularly in the liver and bone. Although systemic therapy has long been the foundation of treatment in patients, particularly with widespread disease, localized treatments of metastatic deposits have been increasingly used and shown to be safe and effective in the control of disease. Moreover, a combination of local and systemic therapy has been shown to improve survival. As the technical advancements in local therapy evolve, it is imperative that patients with metastatic STS are presented in a multidisciplinary setting to ensure that all disease aspects are evaluated and determination of the most effective therapies may be presented to each individual.

Keywords: Soft tissue Sarcoma, Metastasis, Multimodality treatment, Metastatic survival

 

 

 

 

 

 

 

 

 

Multiselect Ultimate Query Plugin by InoPlugs Web Design Vienna | Webdesign Wien and Juwelier SchönmannMultiselect Ultimate Query Plugin by InoPlugs Web Design Vienna | Webdesign Wien and Juwelier Schönmann